Product Information
PREGABALIN 225 MG CAPSULE is a generic product labeled by Cipla USA Inc., priced at $0.0555 per EA under NDC 69097068405. Its NADAC has been published 295 times since Nov 4, 2020.
Strength
225 mg/1
Manufacturer
Cipla USA Inc.NDC
69097068405
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PREGABALINApproval Type
Generic (ANDA)
FDA Application
ANDA212280On Market Since
1/10/2020
Price Statistics
The NADAC for PREGABALIN 225 MG CAPSULE has been published 295 times since Nov 4, 2020, and over the history we have for it it has declined 60.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0555 per EA |
|---|---|
| All-time high | $0.1559 (Dec 16, 2020) |
| All-time low | $0.0529 (Nov 20, 2024) |
| 52-week high | $0.0702 |
| 52-week low | $0.0555 |
| Median price | $0.0861 |
| Average price | $0.0902 |
| Largest weekly change | -29.0% (Nov 20, 2024) |
| Weeks tracked | 295 |
| Tracking since | Nov 4, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the PREGABALIN capsules, CV market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PREGABALIN 225 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 225 MG CAPSULE, manufactured by Cipla USA Inc., is $0.0555 per EA (NDC 69097068405), effective Jun 24, 2026.
How has the price of PREGABALIN 225 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PREGABALIN 225 MG CAPSULE has declined 60.9%. It has been tracked across 295 weekly CMS publications since Nov 4, 2020.
What are the highest and lowest recorded NADAC prices for PREGABALIN 225 MG CAPSULE?
Since Nov 4, 2020, the NADAC for PREGABALIN 225 MG CAPSULE has ranged from a low of $0.0529 (Nov 20, 2024) to a high of $0.1559 (Dec 16, 2020), with a median of $0.0861 per EA.
Are there cheaper alternatives to PREGABALIN 225 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PREGABALIN 225 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures PREGABALIN 225 MG CAPSULE?
PREGABALIN 225 MG CAPSULE (NDC 69097068405) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification